Antibiotic ointment and imaging dye for leg soft tissue sarcoma before surgery
Part of Cancer clinical trials.
This study tests whether adding an antibiotic ointment (to clear bacteria from the skin) and a special dye during surgery can help reduce side effects and improve outcomes for people with soft tissue sarcoma in the leg who are receiving radiation before surgery. If you qualify, you'll receive standard radiation and surgery, plus this extra treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are physically able to care for yourself (able to get out of bed and do light activities).
- You have a newly diagnosed soft tissue sarcoma in your leg, thigh, or buttock area.
- Your doctor plans to remove the tumor with surgery and you are able to receive radiation therapy.
- You have no allergy to the antibiotics mupirocin or chlorhexidine.
- You have not had radiation therapy to the same area before.
- If you are able to become pregnant, a pregnancy test must be negative before starting radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a shorter course of radiation before surgery is effective for soft tissue sarcomas in certain locations. It aims to make treatment more convenient while maintaining good results.
This Phase 2 trial tests whether giving radiation before surgery, along with anlotinib and penpulimab, can improve treatment for localized soft tissue sarcoma. It may help shrink or control the tumor before conservative surgery.
This trial tests a new approach for high-risk soft tissue sarcoma of the arm, leg, or trunk. Before surgery, you would receive chemotherapy combined with local hyperthermia (a treatment that gently heats the tumor area) to see if this can improve outcomes.
This trial tests a shorter course of radiation (just 5 days) before surgery for soft tissue sarcoma. The goal is to see if a brief, high-dose radiation schedule works as well as or better than the usual longer course—and may be more convenient for you.
This trial tests a shorter, 3-week course of radiation therapy (using protons or standard X-rays) given before surgery for localized soft tissue sarcoma. It aims to see if this approach is safe and effective for treating the tumor while reducing side effects.
This trial tests a combination of radiation therapy and two drugs (anlotinib and penpulimab) given before surgery for soft tissue sarcoma. The goal is to see if this approach can shrink tumors and improve outcomes.
Hear when a new Sarcoma,Soft Tissue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.